Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1954 1
1961 1
1963 3
1964 3
1965 2
1966 1
1967 4
1968 3
1969 4
1970 4
1971 7
1972 5
1973 10
1974 3
1975 37
1976 23
1977 28
1978 30
1979 40
1980 60
1981 78
1982 120
1983 131
1984 142
1985 167
1986 233
1987 259
1988 270
1989 352
1990 373
1991 378
1992 382
1993 387
1994 454
1995 543
1996 588
1997 644
1998 705
1999 750
2000 850
2001 1039
2002 1165
2003 1216
2004 1356
2005 1556
2006 1748
2007 1964
2008 2235
2009 2437
2010 2517
2011 2770
2012 2956
2013 3298
2014 3635
2015 3970
2016 2828
2017 2088
2018 2613
2019 3068
2020 3588
2021 3922
2022 4065
2023 3634
2024 2639
2025 150

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61,885 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for non cr
Search for Noun CR instead (1 results)
Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade.
Tsai YT, Schlom J, Donahue RN. Tsai YT, et al. J Exp Clin Cancer Res. 2024 Mar 16;43(1):82. doi: 10.1186/s13046-024-02969-1. J Exp Clin Cancer Res. 2024. PMID: 38493133 Free PMC article. Review.
The paradigm of non-small cell lung cancer (NSCLC) treatment has been profoundly influenced by the development of immune checkpoint inhibitors (ICI), but the range of clinical responses observed among patients poses significant challenges. ...
The paradigm of non-small cell lung cancer (NSCLC) treatment has been profoundly influenced by the development of immune checkpoint i …
Mesothelin promotes brain metastasis of non-small cell lung cancer by activating MET.
Xia S, Duan W, Xu M, Li M, Tang M, Wei S, Lin M, Li E, Liu W, Wang Q. Xia S, et al. J Exp Clin Cancer Res. 2024 Apr 3;43(1):103. doi: 10.1186/s13046-024-03015-w. J Exp Clin Cancer Res. 2024. PMID: 38570866 Free PMC article.
BACKGROUND: Brain metastasis (BM) is common among cases of advanced non-small cell lung cancer (NSCLC) and is the leading cause of death for these patients. ...
BACKGROUND: Brain metastasis (BM) is common among cases of advanced non-small cell lung cancer (NSCLC) and is the leading cause of de …
ALKBH5 promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages.
Hua X, Xu Q, Wu R, Sun W, Gu Y, Zhu S, Liu X, Lv T, Song Y. Hua X, et al. J Exp Clin Cancer Res. 2024 Jun 14;43(1):164. doi: 10.1186/s13046-024-03073-0. J Exp Clin Cancer Res. 2024. PMID: 38872221 Free PMC article.
The N6-methyladenosine (m6A) demethylase, ALKBH5 (alkB homolog 5), is overexpressed in non-small cell lung cancer. However, its role in the tumor microenvironment is unknown. ...Bioinformatic analysis, colorimetric assay to determine m6A RNA methylation, dual luciferase re …
The N6-methyladenosine (m6A) demethylase, ALKBH5 (alkB homolog 5), is overexpressed in non-small cell lung cancer. However, its role …
Evodiamine suppresses non-small cell lung cancer by elevating CD8(+) T cells and downregulating the MUC1-C/PD-L1 axis.
Jiang ZB, Huang JM, Xie YJ, Zhang YZ, Chang C, Lai HL, Wang W, Yao XJ, Fan XX, Wu QB, Xie C, Wang MF, Leung EL. Jiang ZB, et al. J Exp Clin Cancer Res. 2020 Nov 19;39(1):249. doi: 10.1186/s13046-020-01741-5. J Exp Clin Cancer Res. 2020. PMID: 33208183 Free PMC article.
In the present study, we confirmed that evodiamine downregulates MUC1-C, resulting in modulating PD-L1 expression in non-small cell lung cancer (NSCLC). METHODS: Cell viability was measured by MTT assays. ...MUC1-C overexpression is common in female, non-smoker, pat …
In the present study, we confirmed that evodiamine downregulates MUC1-C, resulting in modulating PD-L1 expression in non-small cell l …
Circular RNA circATP9A promotes non-small cell lung cancer progression by interacting with HuR and by promoting extracellular vesicles-mediated macrophage M2 polarization.
Yao Y, Chen C, Wang J, Xuan H, Chen X, Li Z, Yang F, Wang B, Lin S, Li S, Tang D, Gong L, Gao W. Yao Y, et al. J Exp Clin Cancer Res. 2023 Dec 5;42(1):330. doi: 10.1186/s13046-023-02916-6. J Exp Clin Cancer Res. 2023. PMID: 38049814 Free PMC article.
BACKGROUND: CircRNA is recognized for its significant regulatory function across various cancers. However, its regulatory role in non-small cell lung cancer (NSCLC) is still largely uncharted. METHODS: Analysis based on public databases is completed using R software. circA …
BACKGROUND: CircRNA is recognized for its significant regulatory function across various cancers. However, its regulatory role in non …
HIF-1alpha switches the functionality of TGF-beta signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer.
Huang Y, Chen Z, Lu T, Bi G, Li M, Liang J, Hu Z, Zheng Y, Yin J, Xi J, Lin Z, Zhan C, Jiang W, Wang Q, Tan L. Huang Y, et al. J Exp Clin Cancer Res. 2021 Dec 20;40(1):398. doi: 10.1186/s13046-021-02188-y. J Exp Clin Cancer Res. 2021. PMID: 34930376 Free PMC article.
We found that transforming growth factor (TGF)-beta plays a dual function in regulating glycolysis and cell proliferation in non-small cell lung cancer. METHODS: We used the PET/MRI imaging system to observe the glucose metabolism of subcutaneous tumors in nude mice. Energ …
We found that transforming growth factor (TGF)-beta plays a dual function in regulating glycolysis and cell proliferation in non-smal …
Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells.
Liang L, Hui K, Hu C, Wen Y, Yang S, Zhu P, Wang L, Xia Y, Qiao Y, Sun W, Fei J, Chen T, Zhao F, Yang B, Jiang X. Liang L, et al. J Exp Clin Cancer Res. 2019 Feb 12;38(1):71. doi: 10.1186/s13046-019-1093-3. J Exp Clin Cancer Res. 2019. PMID: 30755242 Free PMC article.
BACKGROUND: The efficacy and safety of multikinase inhibitor anlotinib have been confirmed in the treatment of advanced non-small cell lung cancer (NSCLC). However, the direct functional mechanisms of tumor lethality mediated by anlotinib were not fully elucidated, and the …
BACKGROUND: The efficacy and safety of multikinase inhibitor anlotinib have been confirmed in the treatment of advanced non-small cel …
Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC).
Hong W, Xue M, Jiang J, Zhang Y, Gao X. Hong W, et al. J Exp Clin Cancer Res. 2020 Aug 3;39(1):149. doi: 10.1186/s13046-020-01648-1. J Exp Clin Cancer Res. 2020. PMID: 32746878 Free PMC article.
BACKGROUND: Non-small cell lung cancer (NSCLC) cells derived intracellular and extracellular programmed cell death ligand 1 (PD-L1) promoted cancer progression and drug resistance, and facilitated tumor immune evasion. ...
BACKGROUND: Non-small cell lung cancer (NSCLC) cells derived intracellular and extracellular programmed cell death ligand 1 (PD-L1) p …
Long non-coding RNAs in ovarian cancer.
Zhan L, Li J, Wei B. Zhan L, et al. J Exp Clin Cancer Res. 2018 Jun 19;37(1):120. doi: 10.1186/s13046-018-0793-4. J Exp Clin Cancer Res. 2018. PMID: 29921308 Free PMC article. Review.
Long non-coding RNAs (lncRNAs) refer to functional cellular RNAs molecules longer than 200 nucleotides in length. ...
Long non-coding RNAs (lncRNAs) refer to functional cellular RNAs molecules longer than 200 nucleotides in length. ...
61,885 results
You have reached the last available page of results. Please see the User Guide for more information.